Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey.
Aged
Atrioventricular Block
/ epidemiology
COVID-19
/ diagnosis
Comorbidity
Defibrillators, Implantable
/ statistics & numerical data
Female
Global Health
/ statistics & numerical data
Humans
Infection Control
/ instrumentation
Male
Middle Aged
Mortality
Outcome Assessment, Health Care
Pacemaker, Artificial
/ statistics & numerical data
Postoperative Complications
/ diagnosis
Prosthesis Implantation
/ adverse effects
Risk Factors
SARS-CoV-2
/ isolation & purification
Sick Sinus Syndrome
/ epidemiology
Surveys and Questionnaires
Active COVID-19
Cardiac implantable electronic device procedure
Complications
Mortality
Personal protective equipment
Journal
Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
21
06
2021
revised:
16
10
2021
accepted:
20
10
2021
pubmed:
29
10
2021
medline:
8
2
2022
entrez:
28
10
2021
Statut:
ppublish
Résumé
Cardiac implantable electronic device (CIED) implantation rates as well as the clinical and procedural characteristics and outcomes in patients with known active coronavirus disease 2019 (COVID-19) are unknown. The purpose of this study was to gather information regarding CIED procedures during active COVID-19, performed with personal protective equipment, based on an international survey. Fifty-three centers from 13 countries across 4 continents provided information on 166 patients with known active COVID-19 who underwent a CIED procedure. The CIED procedure rate in 133,655 hospitalized COVID-19 patients ranged from 0 to 16.2 per 1000 patients (P <.001). Most devices were implanted due to high-degree/complete atrioventricular block (112 [67.5%]) or sick sinus syndrome (31 [18.7%]). Of the 166 patients in the study survey, the 30-day complication rate was 13.9% and the 180-day mortality rate was 9.6%. One patient had a fatal outcome as a direct result of the procedure. Differences in patient and procedural characteristics and outcomes were found between Europe and North America. An older population (76.6 vs 66 years; P <.001) with a nonsignificant higher complication rate (16.5% vs 7.7%; P = .2) was observed in Europe vs North America, whereas higher rates of critically ill patients (33.3% vs 3.3%; P <.001) and mortality (26.9% vs 5%; P = .002) were observed in North America vs Europe. CIED procedure rates during known active COVID-19 disease varied greatly, from 0 to 16.2 per 1000 hospitalized COVID-19 patients worldwide. Patients with active COVID-19 infection who underwent CIED implantation had high complication and mortality rates. Operators should take these risks into consideration before proceeding with CIED implantation in active COVID-19 patients.
Sections du résumé
BACKGROUND
Cardiac implantable electronic device (CIED) implantation rates as well as the clinical and procedural characteristics and outcomes in patients with known active coronavirus disease 2019 (COVID-19) are unknown.
OBJECTIVE
The purpose of this study was to gather information regarding CIED procedures during active COVID-19, performed with personal protective equipment, based on an international survey.
METHODS
Fifty-three centers from 13 countries across 4 continents provided information on 166 patients with known active COVID-19 who underwent a CIED procedure.
RESULTS
The CIED procedure rate in 133,655 hospitalized COVID-19 patients ranged from 0 to 16.2 per 1000 patients (P <.001). Most devices were implanted due to high-degree/complete atrioventricular block (112 [67.5%]) or sick sinus syndrome (31 [18.7%]). Of the 166 patients in the study survey, the 30-day complication rate was 13.9% and the 180-day mortality rate was 9.6%. One patient had a fatal outcome as a direct result of the procedure. Differences in patient and procedural characteristics and outcomes were found between Europe and North America. An older population (76.6 vs 66 years; P <.001) with a nonsignificant higher complication rate (16.5% vs 7.7%; P = .2) was observed in Europe vs North America, whereas higher rates of critically ill patients (33.3% vs 3.3%; P <.001) and mortality (26.9% vs 5%; P = .002) were observed in North America vs Europe.
CONCLUSION
CIED procedure rates during known active COVID-19 disease varied greatly, from 0 to 16.2 per 1000 hospitalized COVID-19 patients worldwide. Patients with active COVID-19 infection who underwent CIED implantation had high complication and mortality rates. Operators should take these risks into consideration before proceeding with CIED implantation in active COVID-19 patients.
Identifiants
pubmed: 34710561
pii: S1547-5271(21)02311-0
doi: 10.1016/j.hrthm.2021.10.020
pmc: PMC8547796
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
206-216Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 Heart Rhythm Society. All rights reserved.
Références
Europace. 2021 Mar 8;23(3):456-463
pubmed: 33595062
Case Rep Cardiol. 2020 Oct 24;2020:8833660
pubmed: 33133701
Europace. 2021 Jun 7;23(6):928-936
pubmed: 33778881
N Engl J Med. 2016 Jun 30;374(26):2604-5
pubmed: 27355552
J Innov Card Rhythm Manag. 2021 Jan 15;12(1):4368-4370
pubmed: 33520352
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008722
pubmed: 32434373
Rev Esp Cardiol (Engl Ed). 2021 May;74(5):469-472
pubmed: 33349587
Rev Esp Cardiol. 2004 Nov;57(11):1045-52
pubmed: 15544753
Eur Heart J Case Rep. 2020 Nov 14;4(6):1-4
pubmed: 33442589
Eur Heart J Qual Care Clin Outcomes. 2021 May 3;7(3):247-256
pubmed: 33079204
HeartRhythm Case Rep. 2020 Nov;6(11):884-887
pubmed: 32953452
Circulation. 2020 May 26;141(21):e823-e831
pubmed: 32228309
Am J Cardiol. 1982 Feb 1;49(2):301-6
pubmed: 7058746
Eur Heart J Case Rep. 2020 Aug 25;4(FI1):1-6
pubmed: 33089060
Eur Heart J Case Rep. 2020 Jul 30;4(FI1):1-6
pubmed: 33089056
Intern Med J. 2020 Oct;50(10):1207-1216
pubmed: 31762133
Eur Heart J. 2017 Jul 14;38(27):2122-2128
pubmed: 28329322
Ann Intern Med. 2019 Sep 3;171(5):309-317
pubmed: 31357210
Cureus. 2020 Oct 23;12(10):e11115
pubmed: 33240711
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458
pubmed: 33554620
Am J Cardiol. 2003 Sep 15;92(6):740-1
pubmed: 12972124
Pacing Clin Electrophysiol. 2020 Oct;43(10):1199-1204
pubmed: 32820823
Int J Cardiol. 2018 Nov 15;271:98-104
pubmed: 29880299
J Arrhythm. 2020 Jul 23;:
pubmed: 32837668
Heart Rhythm. 2017 Sep;14(9):1375-1379
pubmed: 28502871
SN Compr Clin Med. 2021 Jan 6;:1-4
pubmed: 33432301
J Arrhythm. 2020 Dec 14;37(1):261-263
pubmed: 33664916
Heart Rhythm. 2012 May;9(5):728-35
pubmed: 22182495
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Circ Arrhythm Electrophysiol. 2020 Nov;13(11):e008920
pubmed: 33026892
J Cardiol Cases. 2021 Jan;23(1):27-30
pubmed: 32904735